The Journal of Pediatrics
Volume 154, Issue 1 , Pages 67-73.e1 , January 2009

The Relationship of Retinol Binding Protein 4 to Changes in Insulin Resistance and Cardiometabolic Risk in Overweight Black Adolescents

  • Elizabeth Goodman, MD

      Affiliations

    • The Floating Hospital for Children at Tufts Medical Center, Boston, MA
    • Department of Pediatrics and Public Health, Tufts University School of Medicine, Boston, MA
    • Corresponding Author InformationReprint requests: Elizabeth Goodman, MD, Pediatric Clinical Research Center, Floating Hospital for Children at Tufts Medical Center, 800 Washington St, Box 854, Boston, MA 02111
    • ,
  • Timothy E. Graham, MD

      Affiliations

    • Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
    • ,
  • Lawrence M. Dolan, MD

      Affiliations

    • Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    • ,
  • Stephen R. Daniels, MD, PhD

      Affiliations

    • Department of Pediatrics, University of Denver School of Medicine, Denver, CO
    • ,
  • Eric R. Goodman, BS

      Affiliations

    • The Floating Hospital for Children at Tufts Medical Center, Boston, MA
    • ,
  • Barbara B. Kahn, MD

      Affiliations

    • Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

Received 7 April 2008 ,Revised 16 June 2008 ,Accepted 15 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by NIH grants HD41527, DK59183, DK43051, DK69624, and M01RR 08084. B.B.K. is the recipient of a research grant from Takeda Pharmaceutical Company, consultant to Wyeth and Boehringer Ingelheim and on the speakers' bureau for Merck. S.R.D. is a consultant to Abbott and Schering-Plough. B.B.K. and T.E.G. are inventors on patent applications related to RBP4.

PII: S0022-3476(08)00598-2

doi: 10.1016/j.jpeds.2008.07.018

The Journal of Pediatrics
Volume 154, Issue 1 , Pages 67-73.e1 , January 2009

Article Tools

* Image Usage & Resolution